BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT07022717 updates: 1. completion date: 2026-06-01 → 2026-09-01 2. primary completion date: 2026-06-01 → 2026-09-01
Clinical trial NCT07022717 updates: 1. completion date: 2026-06-01 → 2026-09-01 2. primary completion date: 2026-06-01 → 2026-09-01
Clinical trial NCT06015724 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 54 → 19 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04294498 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-09-01 → 2026-06-29 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04569708 updates: 1. status: COMPLETED → WITHDRAWN 2. enrollment: 30 → 0 participants
Clinical trial NCT06010004: enrollment: 466 → 401 participants.
Clinical trial NCT06601166 updates: 1. status: WITHHELD → ACTIVE_NOT_RECRUITING 2. start date: not set → 2024-08-15 3. completion date: not set → 2026-12-16 4. primary completion date: not set → 2026-05-13 5. enrollment: not set → 283 participants 6. study type: not set → INTERVENTIONAL 7. enrollment type: not set …
Clinical trial NCT07604116 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-15
Clinical trial NCT05600686 updates: 1. completion date: 2028-02-01 → 2027-12-15 2. primary completion date: 2026-02-01 → 2026-10-01
Clinical trial NCT05938270 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-17 → 2026-06-15 3. primary completion date: 2026-08-17 → 2026-06-15 4. enrollment: 120 → 113 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07014020 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. phase: NA → PHASE1 3. enrollment type: ESTIMATED → ACTUAL